MCB-613 exploits a collateral sensitivity in drug resistantEGFR-mutant non-small cell lung cancer through covalent inhibition of KEAP1
Christopher F. Bassil,Gray R. Anderson,Benjamin Mayro,Kayleigh N. Askin,Peter S. Winter, Samuel Gruber, Tierney M. Hall,Jacob P. Hoj,Christian Cerda-Smith,Haley M. Hutchinson,Shane T. Killarney,Katherine R. Singleton,Li Qin, Kévin Jubien-Girard,Cécile Favreau,Anthony R. Martin,Guillaume Robert,Rachid Benhida,Patrick Auberger,Ann Marie Pendergast,David M. Lonard,Alexandre Puissant,Kris C. Wood crossref（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper